🔗 Share this article

Acclaimed soul vocalist D’Angelo passed away on October 14 at 51 years old after a personal fight with pancreatic cancer.

“The shining star of our household has dimmed his light for us in this life,” his family stated. “After a prolonged and courageous struggle with the disease, we are heartbroken to declare that Michael D’Angelo Archer, recognized by his followers around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his innovative neo-soul sound and partnerships with high-profile artists.

He launched his first record, “Brown Sugar,” in 1995 to immediate acclaim. The album achieved No. 4 on Billboard’s Top R&B Albums chart, went platinum later that year, and received multiple award nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his music career into the stratosphere. The album debuted at No. 1 on both the R&B charts and the main album chart. He received two Grammy Awards: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” cemented D’Angelo’s standing as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction featured the singer, notably stripped down to his waist, singing straight into the camera.

D’Angelo stepped back from the spotlight after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was involved in a severe car crash that put him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with a further No. 1 debut on the soul music rankings and a Grammy for Top R&B Record.

Once more, in his own mysterious way, D’Angelo made only a few public outings in the subsequent period.

The musician was scheduled as a top act for the 2025 music event, but his appearance was called off, citing an “unforeseen medical delay.”

Although information is limited about D’Angelo’s well-being in the weeks before his passing, he had reportedly been in the hospital for months and in palliative care for two weeks.

D’Angelo’s passing is a clear example of the devastating effects of pancreatic malignancy, one of the most deadly and hardest to prevent types of the illness, on a brilliant talent whose existence was ended too soon.

“We are saddened that he can only provide cherished moments with his loved ones, but we are eternally grateful for the heritage of extraordinarily moving music he has left us,” his family expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic malignancy impacts the pancreas, a small organ that produces insulin and is vital in breaking down food, among other functions. The size and location of the organ in the body make it more challenging to identify malignancy.

Although this cancer makes up only about 3% of cancer diagnoses each year in the United States, it is responsible for 7% of cancer deaths.

Nearly seventy thousand individuals will be diagnosed with this condition and roughly 52,000 will die of the disease in 2025.

“This malignancy is one of the most lethal diseases, with an aggressive tumor and dismal outcomes. We have limited and ineffective treatment options, and a narrow opportunity to make a meaningful impact on the well-being of people,” said a cancer specialist.

Since pancreatic cancer rarely causes initial signs, it’s frequently diagnosed only once the disease is late-stage. Although a patient has indicators they are usually vague and may be mistaken for a several common illnesses.

“Currently, there is no good way to detect pancreatic cancer in the initial phases, except for listening to your body and consulting your physician if there are new or unusual signs,” explained a medical director.

Common symptoms of this disease encompass:

• discomfort in the stomach or back
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• pale or fatty bowel movements
• diarrhea
• increased appetite or thirst
• feeling sick

At age 51, D’Angelo’s demise is an outlier, as pancreatic cancer is typically found in individuals in the 65 to 75 age bracket. However, many cancers, including this type, have become increasingly prevalent among younger adults.

“This disease identified prior to fifty is considered rare, yet alarmingly, doctors are beginning to see a growing number of younger individuals affected by this condition,” commented a specialist.

Family History Affects Cancer Risk

In the absence of effective detection methods for this malignancy, experts emphasized the significance of understanding your family’s health background. Certain risk factors, such as smoking and obesity also play a role in the onset of this disease.

Black individuals have the highest incidence of pancreatic cancer in the United States and are more prone to be diagnosed with inoperable cancer.

“The initial action toward lowering one’s risk of pancreatic cancer is understanding individual susceptibility. Individuals should examine their genetic background, hereditary factors, and health issues, such as blood sugar disease, chronic pancreatitis, or obesity that may increase their susceptibility,” advised a specialist.

Inherited genetic risk factors are linked to as much as 10% of all pancreatic cancer cases. If a relative in your household has had this disease, you may want to consider genetic testing.

“For people with a relative’s background of this condition or those having high risk DNA changes, checking may involve sophisticated scans such as MRI scans or endoscopic ultrasound (EUS) to detect initial alterations in the organ,” he clarified.

For those wishing to reduce their risk, habit adjustments may make a difference. The best action you can take to lower your risk of pancreatic cancer is to quit smoking, and if you don’t smoke, avoid exposure altogether.

Heavy alcohol consumption is associated with pancreatitis, a risk factor for this malignancy, so reducing or abstaining from drinks may assist lower your chance.

Controlling your weight or losing weight may also aid reduce your risk. People with excess weight are twenty percent more prone to develop pancreatic cancer. This malignancy also occurs more often in people with blood sugar issues, and weight loss can also lower the chance of adult-onset diabetes.

Despite pancreatic cancer’s grim outlook, there is reason for optimism.

“We are making progress with therapies and more recent combination chemotherapy. There are emerging targeted therapies that already are making an impact,” said a specialist.

For numerous individuals, however, awareness about this uncommon but {dev